BIOTRONIK, Charité, and German Heart Center Foundation Announce Partnership to Advance Digital Cardiology
BIOTRONIK, die Charité – Universitätsmedizin Berlin, and the German Heart Center Foundation have announced a research and innovation partnership focused on advancing digital and translational cardiology. The collaboration aims to combine clinical cardiovascular expertise at Deutsches Herzzentrum der Charité (DHZC) with BIOTRONIK's capabilities in active cardiac devices, artificial intelligence, and connected health technologies.
The partnership builds on existing projects in cardiovascular healthcare, including publicly funded initiatives, and will cover a framework that extends from early-stage ideation to joint development and contract research. Initial efforts will concentrate on creating AI-driven tools and advanced simulation environments to enhance device-based therapies.
Dr. Volker Lang, Senior Vice President of Research & Development at BIOTRONIK, stated, "The future of cardiovascular care is digital, connected, and predictive." He emphasized that integrating advanced AI, telemonitoring, and implantable technologies with clinical research is essential for transforming heart care and improving patient outcomes globally.
Prof. Heyo K. Kroemer, Chairman of the Board at Charité, highlighted the importance of the partnership, saying, "This strategic partnership demonstrates how academic medicine and industry research can work together to pave the way for data-driven cardiology." He added that advancing innovation while training the next generation of heart specialists is a critical goal of the collaboration.
In addition, BIOTRONIK and the German Heart Center Foundation are supporting the establishment of an endowed professorship for Digital and Translational Cardiology at Charité. Andreas Portmann, Managing Director of the Foundation, commented that the initiative aims to attract internationally experienced researchers, thereby accelerating innovation and contributing to Berlin’s role as a leading hub for cardiovascular research and advancing Europe’s medical technology sector.